Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Hengrui Therapeutics gets $100mm through Series A round

Executive Summary

Cancer start-up Hengrui Therapeutics Inc. raised $100mm through what appears to be its Series A round. The investment came from HR Bio Holdings Ltd., a joint venture between Jiangsu Hengrui Medicine Co. Ltd. and an undisclosed blue chip investment firm.
Deal Industry
  • Pharmaceuticals
    • Generic Drugs
    • Radiopharmaceuticals, Contrast Agents
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register